No tradeable signal. This is a procedural filing confirming the annual report is available. The 20-F content is unchanged from previous disclosures and was already reviewed. No action required.
RDY drugs
RDY drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 1 $13.26entry
- T+1 · 6mo ago −1.73%α −1.88% · $13.03
- T+5 · 5mo ago −0.15%α +2.60% · $13.24
- T+20 · 5mo ago +9.28%α +10.57% · $14.49
- T+60 · 3mo ago −6.94%α −8.17% · $12.34
Price Chart
How similar events traded
Executive Summary
Dr. Reddy's filed a Form 6-K on May 30, 2026, solely to announce that its annual Form 20-F for the fiscal year ended March 31, 2026 had been filed with the SEC. The filing contains no new financial disclosures, business updates, or material events beyond what was previously reported in the annual report.
Key Facts
- Annual Report in Form 20-F for FY ended March 31, 2026 was filed with the SEC on May 30, 2026
- Annual consolidated financial statements prepared under IFRS
- No additional material information beyond the annual report filing
- This 6-K is a routine regulatory notification for the NYSE-listed foreign private issuer
Financial Impact
None, no new financial data disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000384 |
| Document: 0001575872-26-000384-index.html | 0001575872-26-000384 |
| Document: 0001575872-26-000384.txt | 0001575872-26-000384 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers